Intracerebroventricular administration of ouabain, a Na/K-ATPase inhibitor, activates mTOR signal pathways and protein translation in the rat frontal cortex.
Prog Neuropsychopharmacol Biol Psychiatry
; 45: 73-82, 2013 Aug 01.
Article
en En
| MEDLINE
| ID: mdl-23643758
Palabras clave
4E-BP; 4',6'-diamidino-2-phenylindole; ANOVA; BDNF; Bipolar disorder; DAPI; EGFR; ERK; ICV; MAPK; NMDA; Na-pump; Na/K-ATPase; OD; PKC; PLC; PMS; Protein synthesis; S6; aCSF; analysis of variance; artificial cerebrospinal fluid; brain-derived neurotrophic factor; eIF4B; epidermal growth factor receptor; eukaryotic translation initiation factor 4B; eukaryotic translation initiation factor 4E binding protein; extracellular signal regulated kinase; intracerebroventricular; mTOR; mammalian target rapamycin; mitogen-activated protein kinase; n-methyl-d-aspartate; optical density; p70 ribosomal S6 kinase; p70S6K; phospholipase C; postmitochondrial supernatant; protein kinase C; small ribosomal protein 6; sodium and potassium-activated adenosine triphosphatase
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Ouabaína
/
Biosíntesis de Proteínas
/
Transducción de Señal
/
ATPasa Intercambiadora de Sodio-Potasio
/
Inhibidores Enzimáticos
/
Serina-Treonina Quinasas TOR
/
Lóbulo Frontal
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Prog Neuropsychopharmacol Biol Psychiatry
Año:
2013
Tipo del documento:
Article